Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 12Spondylitis, Ankylosing 4Psoriasis 2Inflammatory Bowel Diseases 2Thyroid Carcinoma, Anaplastic 1Spondylarthritis 1Sarcoidosis 1Osteoarthritis 1Nephrotic Syndrome 1Nephrosis, Lipoid 1Mucopolysaccharidosis VI 1Mucopolysaccharidosis II 1Mucopolysaccharidosis I 1Mucopolysaccharidoses 1Macular dystrophy, corneal type 1 1Kidney Diseases 1Joint Diseases 1Inflammation 1Infections 1Glomerulosclerosis, Focal Segmental 1Dupuytren Contracture 1Crohn Disease 1Colitis, Ulcerative 1Autoimmune Diseases 1Arthritis, Psoriatic 1Arthritis 1

Interventions

Etanercept 2apremilast 1Vaccines 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Infliximab 1Herpes Zoster Vaccine 1Educational Status 1Early Intervention, Educational 1Dietary Fiber 1Anti-Inflammatory Agents, Non-Steroidal 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Arthritis, Psoriatic × Adalimumab × Clear all
NCT01060098 2020-01-18

T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

Imperial College London

Completed
48 enrolled 6 charts

Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡